Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3709303019 | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3709304013 | Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Product containing emtricitabine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Cobicistat-containing product in oral dose form | true | Inferred relationship | Some | ||
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Elvitegravir-containing product in oral dose form | true | Inferred relationship | Some | ||
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) | true | Inferred relationship | Some | ||
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Tenofovir (substance) | true | Inferred relationship | Some | 2 | |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Elvitegravir (substance) | true | Inferred relationship | Some | 3 | |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Cobicistat | true | Inferred relationship | Some | 4 | |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Inferred relationship | Some | |
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) | Is a | True | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets